Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 02, 2015 3:56 PM ET

Life Sciences Tools and Services

Company Overview of PureTech Health plc

Company Overview

PureTech Health plc, a science-driven healthcare company, focuses on developing technologies that seek to address significant healthcare markets. The company, through its subsidiaries and operating companies, engages in developing microbiome immune system drug-discovery platform and drug candidates for the treatment of immune-mediated diseases; and products that seek to induce weight loss and potentially enhance glycaemic control through an orally administered capsule. It is also developing technology and products for the screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for ps...

501 Boylston Street

Suite 6102

Boston, MA 02116

United States

Founded in 2015

61 Employees

Phone:

617-482-2333

Fax:

617-482-3337

Key Executives for PureTech Health plc

Chief Executive Officer, Founder and Executive Director
Age: 44
Total Annual Compensation: $614.9K
Executive Vice President, Legal, Finance and Operations and Executive Director
Age: 45
Total Annual Compensation: $410.4K
Compensation as of Fiscal Year 2014.

PureTech Health plc Key Developments

PureTech Health plc Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2015

PureTech Health plc reported unaudited consolidated earnings results for the six months ended June 30, 2015. For the period, the company reported revenue of $10,989,000 against $1,140,000 a year ago. The increase in revenue is primarily attributable to a $10.0 million non-refundable payment Vedanta Biosciences received as part of its collaboration with Janssen Biotech to develop and commercialise VE202, a microbiome product candidate. Operating loss was $11,606,000 against $4,918,000 a year ago. Loss before taxes was $15,475,000 against $32,837,000 a year ago. The $17.3 million decrease in the first half of 2015 results from a $6.7 million increase in operating loss offset by a decline of $24 million in net finance costs. Loss for the period was $17,234,000 against $32,837,000 a year ago. Net cash outflow from operating activities was $2,054,000 against $3,325,000 a year ago. Basic and diluted loss per share was $0.06 against $0.26 a year ago. Purchase of property and equipment was $2,247,000 against $67,000 a year ago. Loss attributable to owners of the company was $9,327,000 against $16,398,000 a year ago.

PureTech Health plc to Report First Half, 2015 Results on Aug 25, 2015

PureTech Health plc announced that they will report first half, 2015 results on Aug 25, 2015

PureTech Names Marko Ahtisaari as CEO

PureTech announced that it has named a former Nokia executive as its first CEO. Marko Ahtisaari, who served as head of design for the Nokia a few years back, was named to head the startup less than a year after it was launched. Ahtisaari, 45, left his position at Nokia in 2013 after four years, a job he came into after Nokia bought the company he previously co-founded and led, a social networking service called Dopplr. Now, he is a Director's Fellow at the MIT Media Lab.

Similar Private Companies By Industry

Company Name Region
Afmedica, Inc. United States
Grand River Aseptic Manufacturing Inc. United States
Eksigent Technologies, Inc. United States
PharmaCore, Inc. United States
Venenum Biodesign, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 21, 2015
Tal Medical Inc.
Private Placement
January 9, 2015
--
Private Placement
October 20, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PureTech Health plc, please visit www.puretechhealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.